Literature DB >> 7528173

Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor.

M E Grauer1, C Bokemeyer, W Bautsch, M Freund, H Link.   

Abstract

Invasive fungal infections have become an increasing problem in severely immunocompromised hosts. We here report a case of septicemia, caused by Trichosporon beigelii, an unusual pathogen of systemic infections. This infection was acquired during a period of severe neutropenia after chemotherapy for relapsed acute myelogenous leukemia following allogeneic bone marrow transplantation. The patient recovered from a life-threatening T. beigelii septicemia due to early intensified treatment with amphotericin B and a rapid neutrophil recovery, enhanced by granulocyte colony-stimulating factor (G-CSF). According to the current literature, amphotericin B is the treatment of choice for systemic T. beigelii infections. In patients with severe granulocytopenia, the rapid recovery of neutrophils remains the most important factor for the outcome of this infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528173     DOI: 10.1007/bf01739918

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

Review 1.  Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

Authors:  G J Lieschke; A W Burgess
Journal:  N Engl J Med       Date:  1992-07-02       Impact factor: 91.245

2.  Invasive Trichosporon cutaneum infection: an increasing problem in immunosuppressed patients.

Authors:  R M Lowenthal; K Atkinson; D R Challis; R G Tucker; J C Biggs
Journal:  Bone Marrow Transplant       Date:  1987-10       Impact factor: 5.483

3.  Invasive Trichosporon cutaneum (beigelii) infection in a patient with relapsed acute myeloid leukemia undergoing bone marrow transplantation.

Authors:  W Siegert; G Henze; J Wagner; A Rodloff; R Zimmermann; R Malchus; R Schwerdtfeger; A Reichelt; K Gräf; D Huhn
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

4.  In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.

Authors:  G Morace; S Manzara; G Dettori
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

5.  Trichosporon beigelii pneumonia in a neutropenic patient.

Authors:  J Marin; E Chiner; J Franco; R Borras
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

6.  Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.

Authors:  J Crawford; H Ozer; R Stoller; D Johnson; G Lyman; I Tabbara; M Kris; J Grous; V Picozzi; G Rausch
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

7.  Disseminated Trichosporon beigelii infection after orthotopic liver transplantation.

Authors:  M J Ness; R S Markin; R P Wood; B W Shaw; G L Woods
Journal:  Am J Clin Pathol       Date:  1989-07       Impact factor: 2.493

8.  Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy.

Authors:  K Ogata; Y Tanabe; K Iwakiri; T Ito; T Yamada; K Dan; T Nomura
Journal:  Cancer       Date:  1990-06-15       Impact factor: 6.860

9.  Trichosporon beigelii peritonitis.

Authors:  J Parsonnet
Journal:  South Med J       Date:  1989-08       Impact factor: 0.954

10.  Prosthetic valve endocarditis caused by Trichosporon beigelii.

Authors:  H H Reinhart; D M Urbanski; S D Harrington; J D Sobel
Journal:  Am J Med       Date:  1988-02       Impact factor: 4.965

View more
  8 in total

Review 1.  Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.

Authors:  Corrado Girmenia; Livio Pagano; Bruno Martino; Domenico D'Antonio; Rosa Fanci; Giorgina Specchia; Lorella Melillo; Massimo Buelli; Giampaolo Pizzarelli; Mario Venditti; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 2.  Therapy for fungal infections in leukemia.

Authors:  R E Segal; G Y Minamoto
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

3.  Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis.

Authors:  H Muranaka; M Suga; K Nakagawa; K Sato; Y Gushima; M Ando
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 4.  Antifungal agents in the 1990s. Current status and future developments.

Authors:  C A Kauffman; P L Carver
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

5.  PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis.

Authors:  H Nagai; Y Yamakami; A Hashimoto; I Tokimatsu; M Nasu
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  In Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahii.

Authors:  Suteng Yang; Yong Liao; Lin Cong; Xuelian Lu; Rongya Yang
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

Review 7.  Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.

Authors:  João N de Almeida Júnior; Christophe Hennequin
Journal:  Front Microbiol       Date:  2016-10-17       Impact factor: 5.640

8.  Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014.

Authors:  Yong Liao; Xuelian Lu; Suteng Yang; Yi Luo; Qi Chen; Rongya Yang
Journal:  Open Forum Infect Dis       Date:  2015-09-25       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.